The quest for increased productivity and better process control combined with patient safety has encouraged biopharmaceutical companies to use chemically defined media for cell culture.
Michelle Lea, PhD
Advertisement
Michelle Lea, PhD, is a senior fermentation development scientist at Eden Biodesign Ltd.
Articles by Michelle Lea, PhD
Advertisement
Latest Updated Articles
Balancing Media Development with Patient SafetyPublished: June 2nd 2010 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
5
